Impilo divests leading haemostatic device developer and manufacturer Ferrosan Medical Devices to Danish consortium of long-term investors

Impilo AB (“Impilo”) and other minority investors, incl. Hans-Christian Bødker Jensen, have signed an agreement to divest the Danish medical devices company Ferrosan Medical Devices Group A/S (“FeMD”) to a consortium of Danish long-term investors consisting of Kirk Kapital, Lundbeckfonden and ATP (the “Consortium”).

Impilo invested in FeMD in 2017 and has together with the management team realised the vision of creating a world leading medical devices group with product innovation and improved health outcomes at the core of its business. During Impilo’s ownership, revenues and EBITDA have doubled, substantial efforts have been put into bolstering the product innovation pipeline and large investments have gone into expanding the capacity at the company’s manufacturing sites, creating more than 100 new jobs. Further, FeMD has taken important steps towards becoming a more sustainable medical device company by increasing transparency and setting clear targets for its commitments to the environment, employees and patients.